Selected Publications
-
article
- Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.. Bone marrow transplantation. 2024
- Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation.. Transplantation and cellular therapy. 2024
- In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy.. Transplantation and cellular therapy. 2024
- Optimization of Older Adults by a Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR T-Cell Therapy.. Blood advances. 8:3785-3797. 2024
- Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy.. Transplantation and cellular therapy. 30:788.e1-788.e9. 2024
- Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines.. Transplantation and cellular therapy. 30:646-662. 2024
- High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy.. Leukemia & lymphoma. 65:1-1023. 2024
- Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.. Journal of geriatric oncology. 15:-. 2024
- How I Treat Anemia in Older Adults.. Blood. 143:205-213. 2024
- Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. – A review of techniques and analysis of outcomes. Leukemia & Lymphoma. 2024
- Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly.. Hematology (Amsterdam, Netherlands). 28:1-8. 2023
- Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.. JAMA network open. 6:-. 2023
- Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG).. Journal of geriatric oncology. 15:-. 2023
- WT1. Leukemia & lymphoma. 64:1-11. 2023
- FLT3. Haematologica. 108:2234-2239. 2023
- A Study of Physical Resilience and Aging (SPRING): Conceptual framework, rationale, and study design.. Journal of the American Geriatrics Society. 71:2393-2405. 2023
- Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.. Annals of internal medicine. 176:913-921. 2023
- Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.. Transplantation and cellular therapy. 29:515.e1-515.e7. 2023
- The Transplant Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Patients.. Transplantation and cellular therapy. 29:632.e1-632.e10. 2023
- Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.. Cancer medicine. 12:11248-11253. 2023
- Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy.. Journal of the National Comprehensive Cancer Network : JNCCN. 21:373-382.e1. 2023
- Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.. Blood advances. 7:963-970. 2023
- High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.. American journal of hematology. 98:848-856. 2023
- A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.. Blood advances. 7:285-292. 2023
- Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).. PLOS digital health. 2:-. 2023
- Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab.. Transplantation and cellular therapy. 29:314-320. 2023
- Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis.. American journal of hematology. 98:588-597. 2023
- A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B cell lymphoma.. Blood advances. 2023
- Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation.. Bone marrow transplantation. 58:346-348. 2022
- Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.. Journal of the National Cancer Institute. 114:1484-1491. 2022
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Adults with Fusions Associated with Ph-like ALL.. Blood advances. 6:4936-4948. 2022
- Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML).. Leukemia & lymphoma. 63:1-3236. 2022
- Total Marrow and Lymphoid Irradiation with Post-Transplant Cyclophosphamide for Patients with AML in Remission.. Transplantation and cellular therapy. 28:368.e1-368.e7. 2022
- High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia.. American journal of hematology. 97:E171-E173. 2022
- Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer. JCO Oncology Practice. 2022
- Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.. British journal of haematology. 196:e71-e74. 2021
- Allogeneic hematopoietic cell transplantation for older patients.. Hematology. American Society of Hematology. Education Program. 2021:254-263. 2021
- Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation.. Leukemia & lymphoma. 63:1-1226. 2021
- Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens.. Bone marrow transplantation. 57:232-242. 2021
- Unexplained anemia of aging: Etiology, health consequences, and diagnostic criteria.. Journal of the American Geriatrics Society. 70:891-899. 2021
- Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.. Cancer. 128:529-535. 2021
- Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.. Transplantation and cellular therapy. 27:993.e1-993.e8. 2021
- Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.. Blood cancer journal. 11:-. 2021
- Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation.. Bone marrow transplantation. 56:2464-2470. 2021
- Advances in Management for Older Adults With Hematologic Malignancies.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39:2102-2114. 2021
- Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.. Bone marrow transplantation. 56:2575-2581. 2021
- The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core.. Journal of geriatric oncology. 12:1164-1165. 2021
- Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).. American journal of hematology. 96:E196-E200. 2021
- Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.. Transplantation and cellular therapy. 27:617.e1-617.e7. 2021
- Characterize, Optimize, and Harmonize: Caring for Older Adults With Hematologic Malignancies.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 1-9. 2021
- Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39:1001-1009. 2021
- Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies.. Transplantation and cellular therapy. 27:255.e1-255.e9. 2020
- Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.. Journal of geriatric oncology. 12:585-591. 2020
- Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia.. The Journal of clinical endocrinology and metabolism. 105:3396-403. 2020
- Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 26:2335-2345. 2020
- Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies.. Journal of geriatric oncology. 12:235-238. 2020
- Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.. American journal of hematology. 95:1193-1199. 2020
- Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38:3698-3715. 2020
- Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.. Blood advances. 4:2810-2820. 2020
- Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.. Bone marrow transplantation. 55:2204-2206. 2020
- Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.. British journal of haematology. 190:e48-e51. 2020
- Securing the graft during pandemic: are we ready for cryopreservation for all?. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 26:e145-e146. 2020
- A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia.. International journal of cardiology. 95-99. 2020
- Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 26:1025-1027. 2020
- A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. Blood Advances. 2020
- Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.. Blood advances. 3:3488-3498. 2019
- Use of geriatric assessment in hematopoietic cell transplant.. Journal of geriatric oncology. 11:225-236. 2019
- Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.. Leukemia. 33:2599-2609. 2019
- Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24:726-733. 2017
- Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).. Breast cancer research and treatment. 163:391-398. 2017
- Survivorship care for older adults with cancer: U13 conference report.. Journal of geriatric oncology. 7:305-12. 2016
- Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22:1348-1356. 2016
- Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29:1290-6. 2011
-
document